We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

496 hedge funds and large institutions have $12.4B invested in Edwards Lifesciences in 2014 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 157 increasing their positions, 163 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

370% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 20

100% more funds holding in top 10

Funds holding in top 10: 5 → 10 (+5)

53% more capital invested

Capital invested by funds: $8.09B → $12.4B (+$4.31B)

27% more call options, than puts

Call options by funds: $44.2M | Put options by funds: $34.7M

16% more funds holding

Funds holding: 428 → 496 (+68)

4% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 163

12.58% less ownership

Funds ownership: 536.01% → 523.44% (-13%)

Holders
496
Holders Change
+68
Holders Change %
+15.89%
% of All Funds
14.39%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.29%
New
94
Increased
157
Reduced
163
Closed
20
Calls
$44.2M
Puts
$34.7M
Net Calls
+$9.45M
Net Calls Change
+$5.87M

Top Buyers

1
GIM
Generation Investment Management
United Kingdom
+$123M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$91.3M
3
Two Sigma Investments
Two Sigma Investments
New York
+$66.6M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$58.9M
5
JP Morgan Chase
JP Morgan Chase
New York
+$50.4M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$582M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$168M
3
SDJVC
St. Denis J. Villere & Co
Louisiana
-$119M
4
FC
Fairpointe Capital
Illinois
-$86.9M
5
Norges Bank
Norges Bank
Norway
-$69.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$69M +$58.9M +3,728,334 +1,139%
JP Morgan Chase
27
JP Morgan Chase
New York
$67.2M +$50.4M +3,195,300 +425%
Franklin Resources
28
Franklin Resources
California
$65.5M -$133K -8,400 -0.2%
UBS AM
29
UBS AM
Illinois
$65.2M +$14.2M +899,916 +31%
TCIM
30
TIAA CREF Investment Management
New York
$64.6M +$9.69M +613,692 +19%
Mackenzie Financial
31
Mackenzie Financial
Ontario, Canada
$63.5M -$11.2M -712,200 -16%
First Trust Advisors
32
First Trust Advisors
Illinois
$58.5M +$39.9M +2,528,616 +278%
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$54M +$43.6M +2,763,744 +676%
GC
34
Guggenheim Capital
Illinois
$53.7M -$27.9M -1,768,686 -36%
CNB
35
City National Bank
California
$53.1M +$4.31M +272,790 +10%
Legal & General Group
36
Legal & General Group
United Kingdom
$47.5M -$691K -43,764 -2%
NI
37
Numeric Investors
Massachusetts
$44.4M +$39.8M +2,521,950 +2,879%
DL
38
Delta Lloyd
Netherlands
$43.3M +$1.82M +115,470 +22%
Fidelity International
39
Fidelity International
Bermuda
$43M +$28.4M +1,802,136 +250%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$42.2M +$9.99M +632,688 +34%
HCM
41
Highbridge Capital Management
New York
$42M +$35.3M +2,238,720 +980%
CIP
42
Champlain Investment Partners
Vermont
$40.8M -$6.53M -413,580 -15%
Citadel Advisors
43
Citadel Advisors
Florida
$40.2M +$17.1M +1,082,874 +85%
Charles Schwab
44
Charles Schwab
California
$39.4M +$13.3M +841,416 +57%
Deutsche Bank
45
Deutsche Bank
Germany
$39.3M +$3.32M +210,042 +10%
Invesco
46
Invesco
Georgia
$37.9M +$3.92M +248,184 +13%
SGAM
47
Smith Group Asset Management
Texas
$37M +$205K +12,960 +0.6%
CCI
48
Columbus Circle Investors
$36.3M +$33.6M +2,130,630 New
Morgan Stanley
49
Morgan Stanley
New York
$35.8M +$8.56M +542,364 +35%
BlackRock
50
BlackRock
New York
$32.4M +$506K +32,058 +2%
1
2
3 4 5

EW Hedge Fund Activity: Q3 2014 in Review

496 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2014, worth a combined $12.4B — up 53% from $8.09B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new EW positions and 20 closed out — a net gain of 74 holders — while 157 added to existing stakes and 163 trimmed.

The largest buyer was Generation Investment Management, adding an estimated $123M. The largest seller was Capital World Investors, cutting an estimated $582M.

  • 496 institutional investors held Edwards Lifesciences (EW) as of Q3 2014, up from 428 in Q2 2014.
  • Funds reported $12.4B of Edwards Lifesciences stock for Q3 2014, up 53% quarter-over-quarter.
  • 94 funds opened new Edwards Lifesciences positions in Q3 2014 and 20 closed out, a net change of +74 holders.
  • The largest Edwards Lifesciences buyer in Q3 2014 was Generation Investment Management, an estimated $123M added.
  • The largest Edwards Lifesciences seller in Q3 2014 was Capital World Investors, an estimated $582M sold.

Based on aggregated 13F filings for Q3 2014.